Table I.
Groups | Surviving animals (n) | Body weight (g)
|
Tumor weight (g) | Inhibition rate (%) | |
---|---|---|---|---|---|
Start | End | ||||
Control | 6 | 20.2±0.30 | 24.98±1.17 | 1.40±0.18 | |
Treatment | |||||
3 mg/kg | 6 | 20.88±0.36 | 24.58±1.22 | 0.91±0.23a | 34.59 |
6 mg/kg | 6 | 20.77±0.47 | 24.61±1.08 | 0.62±0.23c | 55.78 |
9 mg/kg | 6 | 20.58±0.58 | 23.90±1.40 | 0.38±0.16c | 73.18 |
P<0.05 vs. the vehicle control;
P<0.01 vs. the vehicle control;
P<0.001 vs. the vehicle control. Treatment groups were administered 13-methyl-palmatrubine at different doses.